Bioelectrical Response to Preoperative Hydration in Colorectal Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital of Split

About this trial

This single-center study will evaluate whether short-term changes in bioelectrical impedance measurements after a standardized preoperative intravenous fluid infusion can help predict complications following elective colon or rectal surgery. The prospective group will include 120 consecutive adults. After emptying the bladder, participants will be weighed and assessed barefoot on a standing multifrequency bioelectrical impedance device. They will then receive Ionolyte, a balanced isotonic crystalloid, at 15 mL/kg based on the lower of actual and ideal body weight, up to 1,000 mL, over exactly 40 minutes. Participants will empty the bladder again and undergo repeat measurement 60 minutes after infusion start. The main predictor is the continuous change in phase angle, and the main outcome is at least one Clavien-Dindo grade II-V complication within 30 days. A supportive analysis will compare clinical outcomes with 240 consecutive historical controls using existing hospital records. The historical controls do not receive the study procedure and are not included in the prospective enrollment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 years or older

Scheduled for elective colon or rectal resection at University Hospital of Split

Written informed consent before research-specific procedures

Able to stand safely and complete both BIA measurements

Disqualifiers

Emergency surgery

eGFR below 60 mL/min/1.73 m² or oliguria

Heart failure or clinically significant cardiac disease making fluid loading inappropriate

Edema, pulmonary congestion, or clinically significant ascites

Trial design

Design model

Single group

Treatments tested in this trial

  • Ionolyte Balanced Isotonic Crystalloid

    Drug

    Ionolyte is administered intravenously at 15 mL/kg dosing weight, up to a maximum of 1,000 mL, over exactly 40 minutes. Dosing weight is the lower of actual body weight measured at T0 and ideal body weight calculated from sex and height using the Robinson equations. The infusion rate in mL/h equals the total volume multiplied by 1.5.

Treatment groups

120 Participants
are divided into 1 treatment group
Group A: Standardized Ionolyte Hydration and Serial BIAExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Participants With at Least One Clavien-Dindo Grade II-V Postoperative Complication

Number and proportion of participants experiencing at least one postoperative complication graded II, III, IV, or V according to the Clavien-Dindo classification.

Time frame
From surgery through postoperative day 30

Secondary outcomes

1

Change in Phase Angle

Whole-body/software-reported phase angle at T60 minus T0, analyzed continuously.

Time frame
T0 to 60 minutes after infusion start
2

Change in Extracellular Water

Extracellular water at T60 minus extracellular water at T0, measured in kilograms and analyzed continuously.

Time frame
T0 to 60 minutes after infusion start
3

Major Postoperative Complications

Participants with at least one Clavien-Dindo grade III-V complication.

Time frame
Through postoperative day 30
4

Comprehensive Complication Index

Cumulative postoperative morbidity on the 0-100 CCI scale; higher scores indicate greater morbidity.

Time frame
Through postoperative day 30

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: